Five Prime Therapeutics Inc
B7-H4 ANTIBODY DOSING REGIMENS
Last updated:
Abstract:
The present disclosure provides methods of administering antibodies and antigen-binding fragments thereof that specifically bid to human B7-H4 to a subject in need thereof, for example, a cancer patient.
Status:
Application
Type:
Utility
Filling date:
19 Aug 2020
Issue date:
11 Mar 2021